IMCD to acquire Whawon Pharm.

IMCD, a leading distributor of speciality chemicals and food ingredients, agreed to acquire 57% of the outstanding shares of South Korean based pharmaceutical ingredient distributor Whawon Pharm. In 2018, the company generated a revenue of KRW 57bn ($49m) with 54 employees. "MCD is an ideal partner for Whawon as they share a similar business culture and have a highly dedicated global pharmaceutical presence. We look forward to utilising their technical capability to further develop growth for our customers and suppliers," Young-Hee Won, Whawon CEO.